BamSEC and AlphaSense Join Forces
Learn More

NexImmune Inc.

OTC: NEXI    
Share price (1/8/25): $0.10    
Market cap (1/8/25): $142 thousand
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10.7 2
from 10-K 16 pages Consulting Agreement
12/34/56
EX-10.2
from 10-Q 1 page First Amendment to Employment Agreement
12/34/56
EX-10.3
from 10-Q 20 pages Joint Research Agreement
12/34/56
EX-10.2
from 10-Q 9 pages Employment Agreement
12/34/56
EX-10.8.2
from 10-K 10 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 7 pages February 12, 2022 Mr. Scott Carmer Re: Separation Agreement Dear Scott: You Are Resigning as the Chief Executive Officer of Neximmune, Inc. (The “Company”). the Purpose of This Letter Agreement (This “Agreement”) Is to Set Forth the Terms of Your Resignation From the Company
12/34/56
EX-10.10
from 10-Q 4 pages Neximmune, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.10
from S-1/A 2 pages Neximmune, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.9
from S-1/A 7 pages Neximmune-Knight Employment Agreement
12/34/56
EX-10.8
from S-1/A 7 pages Employment Agreement
12/34/56
EX-10.7
from S-1/A 6 pages Employment Agreement
12/34/56
EX-10.6
from S-1/A 6 pages Employment Agreement
12/34/56
EX-10.5
from S-1/A 10 pages Employment Agreement
12/34/56
EX-10.4.2
from S-1/A 17 pages Neximmune, Inc. 2021 Equity Incentive Plan Stock Option Award Agreement
12/34/56
EX-10.4.1
from S-1/A 25 pages Neximmune, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.3.2
from S-1/A 10 pages Neximmune, Inc. Stock Option Grant Notice Stock Option Grant Under the Company’s 2018 Equity Incentive Plan
12/34/56
EX-10.3.1
from S-1/A 32 pages Neximmune, Inc. 2018 Equity Incentive Plan
12/34/56
EX-10.2.2
from S-1/A 10 pages Neximmune, Inc. Stock Option Grant Notice Stock Option Grant Under the Company’s 2017 Equity Incentive Plan
12/34/56
EX-10.2.1
from S-1/A 25 pages Neximmune, Inc. 2017 Equity Incentive Plan
12/34/56